Module 2.7.1 Summary of Biopharmaceutic Studies and ...

BCS Biopharmaceutics Classification System CI Confidence Interval Cmax Maximum observed concentration Cτ Pre-dose (trough) concentration at the end of the dosing interval CV Coefficient of variance DCS Developability Classification System DTG Dolutegravir FaSSIF Fasted state simulated intestinal fluid GLS Geometric Least-Squares h or hr Hour(s)

  Classification, Biopharmaceutics, Biopharmaceutics classification

1092 THE DISSOLUTION PROCEDURE: DEVELOPMENT AND …

For compounds with high solubility and high permeability (as defined by the Biopharmaceutics Classification System), the choice of medium and apparatus may be influenced by the referenced FDA Guidance1. For very poorly soluble compounds, aqueous solutions may contain a percentage of a surfactant (e.g., sodium lauryl

  Classification, Biopharmaceutics, Biopharmaceutics classification

PHARMACIST EVALUATING EXAMINATION SYLLABUS

Bacterial structure, replication and classification Bacterial pathogenesis and virulence factors Normal microbial flora / Host response to infection Principles of diagnostic microbiology Bacterial Infections ... This includes the role of biopharmaceutics, pre-formulation

  Classification, Biopharmaceutics

SYLLABUS FOR B. PHARM.

SYLLABUS FOR B. PHARM. All India Council for Technical Education . 7th Floor, Chander Lok Building, Janpath, New Delhi